TNYA
TNYA
NASDAQ · Biotechnology

Tenaya Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$0.81
+0.06 (+8.20%)
As of Feb 8, 2:06 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 13 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +4,354.7% upside
Low Target $26.32
Average Target $36.15
High Target $48.95
Current Price $0.81
Current
$0.81
Target
$36.15
$26.32 $36.15 avg $48.95
Scenario Analysis
Bear Case
$26.32
3,143.4%
Low target
Base Case
$36.15
+4,354.7%
Avg target
Bull Case
$48.95
+5,932.0%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$35.46
-97.7% from high
52-Week Low
$25.44
+-96.8% from low
Target vs 52W High
$36.15
+1.9% vs high
Next Earnings Report
Mar 2, 2026 · After Market Close
14d
until earnings
EPS Est: $-0.12
Earnings in 14 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
 Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
 Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
 Hold 42 48% $91.45 -54.5%